APA (7th ed.) Citation

Smalley, R. V., Lefante, J., Bartolucci, A., Carpenter, J., Vogel, C., & Krauss, S. (1983). A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer. Breast Cancer Research and Treatment, 3(2), 209. https://doi.org/10.1007/bf01803563

Chicago Style (17th ed.) Citation

Smalley, Richard V., John Lefante, Alfred Bartolucci, John Carpenter, Charles Vogel, and Stephen Krauss. "A Comparison of Cyclophosphamide, Adriamycin, and 5-fluorouracil (CAF) and Cyclophosphamide, Methotrexate, 5-fluorouracil, Vincristine, and Prednisone (CMFVP) in Patients with Advanced Breast Cancer." Breast Cancer Research and Treatment 3, no. 2 (1983): 209. https://doi.org/10.1007/bf01803563.

MLA (9th ed.) Citation

Smalley, Richard V., et al. "A Comparison of Cyclophosphamide, Adriamycin, and 5-fluorouracil (CAF) and Cyclophosphamide, Methotrexate, 5-fluorouracil, Vincristine, and Prednisone (CMFVP) in Patients with Advanced Breast Cancer." Breast Cancer Research and Treatment, vol. 3, no. 2, 1983, p. 209, https://doi.org/10.1007/bf01803563.